The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Chimerix; Oncoceutics; p53-Therapeutics; SMURF-Therapeutics
Consulting or Advisory Role - Rain Therapeutics
Research Funding - Chimerix; D&D Pharmatech
Patents, Royalties, Other Intellectual Property - Patent on therapeutic targeting on hypoxia-inducible factors; Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
(OPTIONAL) Uncompensated Relationships - As above
 
Stephanie L. Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Academy for Continued Healthcare Learning; DAVA Oncology; IntegrityCE; Med IQ; Medical Educator Consortium; MedPage Today; MJH Life Sciences; Pfizer; WebMD/Medscape
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Seagen
 
Christopher G. Azzoli
Research Funding - Bristol Myers Squibb
 
Don S. Dizon
Stock and Other Ownership Interests - Midi
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Midi
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
Other Relationship - Global Cancer Institute
 
Mary Anne Fenton
Employment - Astellas Pharma (I)
Consulting or Advisory Role - ClinicalPath
Research Funding - Pfizer
 
William M. Sikov
No Relationships to Disclose
 
Howard Safran
No Relationships to Disclose
 
Hina Khan
Consulting or Advisory Role - Genzyme
Research Funding - Robert A. Winn Diversity in Clinical Trials Award Program
 
Humera Khurshid
No Relationships to Disclose
 
Andrew Schumacher
No Relationships to Disclose
 
Lanlan Zhou
No Relationships to Disclose
 
Shuai Zhao
No Relationships to Disclose
 
Attila A. Seyhan
No Relationships to Disclose
 
Dinara Ryspayeva
No Relationships to Disclose
 
Roxanne Wood
No Relationships to Disclose
 
Arthur Winer
No Relationships to Disclose
 
Elizabeth Martine Calleja
No Relationships to Disclose
 
Eric A. Ross
No Relationships to Disclose